• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profusa, Inc. - Common Stock (NQ:PFSA)

2.880 -0.120 (-4.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Profusa, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
August 31, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
August 20, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Sphere 3D (NASDAQ: ANY) Among AIXC, CAST, XOS as Energized Power Fuels AI, HPC Data Center Strategy
August 18, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
Profusa Announces 1-for-4 Reverse Stock Split
August 13, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
July 31, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
July 27, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces 1-for-25 Reverse Stock Split
July 02, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
June 24, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
June 12, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
June 10, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces Listing Transfer to The Nasdaq Capital Market
May 15, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Receives Favorable Nasdaq Listing Determination
May 08, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
May 05, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
April 06, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
February 27, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
February 19, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
February 13, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
February 12, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Announces 1-for-75 Reverse Stock Split
February 05, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
$6 Billion Peripheral Artery Disease (PAD) Market: Innovation at a Premium (PFSA, BSX, ABT)
January 30, 2026
Via AB Newswire
News headline image
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
January 29, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
January 16, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
January 08, 2026
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
December 31, 2025
From Profusa, Inc.
Via GlobeNewswire
News headline image
Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases
December 30, 2025
Via AB Newswire
Topics Intellectual Property
News headline image
Peraso Inc. (NASDAQ: PRSO) Taps $15B U.S. Market as Robotaxi Fleets Hit the Fast Lane
December 30, 2025
Via AB Newswire
News headline image
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
December 30, 2025
From Profusa, Inc.
Via GlobeNewswire
News headline image
Santa’s Rally: CMCT, SURG, SIDU, MYSE, AZI – Stocks Under $5 to Watch Now – More Inside
December 22, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
December 15, 2025
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
December 11, 2025
From Profusa, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap